FOLH1 and metastatic neoplasm: noted that the non-concordance rate between CI and 68Ga-PSMA-11 PET/CT was nearly 30%, and 68Ga-PSMA-11 PET/CT identified 20% of pelvic nodal disease and up to 10% of distant metastatic disease that was negative on CI [28].